[TVTX] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
07-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -449.66%
YoY- -122.97%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 48,487 47,407 47,769 39,570 38,432 33,620 29,008 8.93%
PBT -75,919 -53,554 -18,168 -40,576 -18,149 -13,154 6,146 -
Tax 52 313 -18,976 401 229 -2,064 -5,070 -
NP -75,971 -53,867 808 -40,977 -18,378 -11,090 11,216 -
Tax Rate - - - - - - 82.49% -
Total Cost 124,458 101,274 46,961 80,547 56,810 44,710 17,792 38.27%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -156.68 -113.63 1.69 -103.56 -47.82 -32.99 38.67 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -1.20 -0.96 0.02 -0.99 -0.46 -0.29 0.31 -
EPS Diluted -1.20 -0.96 0.02 -0.99 -0.46 -0.28 -0.08 57.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.